Tacrolimus Ointment
Product Images NDC 0168-0416

7 FDA label images from E. Fougera & Co. A Division Of Fougera Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tacrolimus (NDC 0168-0416). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by E. Fougera & Co. A Division Of Fougera Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Tacro Oint 01)

Structural Formula (Tacro Oint 01)
Chemical structure diagram of tacrolimus, the active ingredient in the topical ointment product Tacrolimus. The structure shows its complex molecular arrangement including ring systems and various functional groups.*
FDA Label Image

Figure 1 (Tacro Oint 02)

Figure 1 (Tacro Oint 02)
A line graph depicting the percentage of body surface area affected over a 12-week period, comparing three groups: Vehicle, Tacrolimus 0.03%, and Tacrolimus 0.1%. The y-axis shows % body surface area affected with mean ± 95% confidence intervals, and the x-axis shows time in weeks. Both Tacrolimus concentrations show a decreasing trend in affected area compared to the Vehicle group.*
FDA Label Image

Figure 2 (Tacro Oint 03)

Figure 2 (Tacro Oint 03)
A line graph showing percent body surface area affected over time in weeks (0 to 12 weeks). Two treatment groups are compared: Vehicle (filled circles) and 0.03% Tacrolimus ointment (open circles). The graph shows a decrease in affected body surface area over time for the 0.03% group, while the Vehicle group remains relatively steady.*
FDA Label Image

Figure 3 (Tacro Oint 04)

Figure 3 (Tacro Oint 04)
Line graph showing the change in mean erythema score over 12 weeks for three groups: Vehicle, 0.03% tacrolimus ointment, and 0.1% tacrolimus ointment. The y-axis represents mean erythema score (mean ± 95% CI), and the x-axis shows time in weeks. Both tacrolimus concentrations show decreasing erythema scores compared to Vehicle over time.*
FDA Label Image

Figure 4 (Tacro Oint 05)

Figure 4 (Tacro Oint 05)
A line graph comparing the mean erythema score (mean ± 95% CI) over 12 weeks for two groups: vehicle and 0.03% tacrolimus ointment. The x-axis represents time in weeks, and the y-axis shows the mean erythema score. The 0.03% tacrolimus group shows a decreasing erythema score over time compared to the vehicle group.*
FDA Label Image

Carton003percent (Tacro Oint 06)

Carton003percent (Tacro Oint 06)
Tacrolimus Ointment 0.03% packaging label showing a 60 gram topical ointment by E. Fougera & Co. The label includes dosage instructions, storage information, and safety warnings such as keeping out of reach of children and that the product is for dermatologic use only. The label features the NDC 0168-0417-60 and highlights that it is a prescription-only medication.*
FDA Label Image

Carton01percent (Tacro Oint 07)

Carton01percent (Tacro Oint 07)
Packaging label for Tacrolimus Ointment 0.1%, a topical human prescription drug by E. Fougera & Co. The label indicates a net weight of 60 grams and includes dosage instructions to apply twice daily. It features storage information and warnings such as keeping out of reach of children and for dermatologic use only. The NDC number 0168-0416-60 is also displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.